What is Allogene Therapeutics's total revenue?

Allogene Therapeutics (ALLO) reported total revenue of $0 in Q4 2025.

What is the long-term trend for Allogene Therapeutics's total revenue?

Over 4 years (2021 to 2025), Allogene Therapeutics's total revenue has grown at a -100.0% compound annual growth rate (CAGR), from $114.09M to $0.

What does total revenue mean?

The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.

Allogene Therapeutics ALLO Total Revenue

Discontinued — last reported Q4 '25

Total Revenue at other companies

Bristol-Myers SquibbBMY

$11.49B+2.6%

Gilead SciencesGILD

$6.96B+4.4%

PrecigenPGEN

$23.25M+1,634%

CRISPR TherapeuticsCRSP

$1.46M+68.6%

CytomX TherapeuticsCTMX

$10.26M-79.9%

Janux TherapeuticsJANX

$3.73M—

Other financials

Income statement

See full

Operating income-$46.1M+29.3%

Net income-$42.6M+28.7%

EPS (diluted)-$0.18+35.7%

Balance sheet

See full

Cash & equivalents$40.6M-23.0%

Total debt$81.1M-8.9%

Total equity$278.9M-27.6%

Total assets$396.0M-22.1%

Cash flow

See full

Operating cash flow-$12.9M+75.6%

CapEx$9.0K-90.9%

Free cash flow-$12.9M+75.6%

Valuation

See full

Market cap$711.02M+164%

Enterprise value$751.47M+146%

Profitability

See full

Operating margin-1,241,813.6%-2,018,140pp

Net margin-1,170,863.6%-2,007,890pp

FCF margin-913,609.1%-1,474,890pp

Returns & leverage

See full

Return on equity-52.3%-5.7pp

Debt / equity0.3×+0.1×

Current ratio9.6×-0.1×

Where this comes from

Reported directly by Allogene Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: Allogene Therapeutics’s 10-K, filed March 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Allogene Therapeutics's total revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Allogene Therapeutics's total revenue?: Allogene Therapeutics (ALLO) reported total revenue of $0 in Q4 2025.
What is the long-term trend for Allogene Therapeutics's total revenue?: Over 4 years (2021 to 2025), Allogene Therapeutics's total revenue has grown at a -100.0% compound annual growth rate (CAGR), from $114.09M to $0.
What does total revenue mean?: The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.